Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
John Tsai
Biotech
Madrigal COO departs days after new CEO starts—Chutes & Ladders
Madrigal COO exits shortly after CEO Sibold starts. John Tsai set to lead new UK biotech. Editas names former Biogen exec to be new commercial lead.
Max Bayer
,
Gabrielle Masson
Sep 29, 2023 9:30am
Novartis says bye to Tsai as restructuring triggers R&D changes
Apr 4, 2022 7:35am
JPM, Day 2: Sanofi continues deal spree, BI's dark antigen pact
Jan 12, 2021 9:05am
JPM: Novartis CMO on how the pandemic is changing R&D
Jan 12, 2021 8:00am
